The AACR Scientist-Survivor Program lets cancer advocates network with the scientists who are driving cancer research.
This year, I was among the advocates for patients with cancer who applied for and were selected to participate in the American Association for Cancer Research (AACR) Scientist↔Survivor Program (SSP). As part of the program, I attended the AACR 2016 Annual Meeting held April 16-20 in New Orleans.
The program consisted of an orientation day, including an excellent “Cancer 101” briefing by Dr. Carolyn Compton; SSP-only sessions in which advocates met with top researchers to discuss specific topics such as immunotherapy and FDA policies; presentation of an original poster during an AACR poster session; a group project in which a scientific advisor and an experienced SSP mentor helped us explore a major aspect of cancer research; evening networking events; and, of course, attending the Annual Meeting with cancer researchers.
Posters created by advocates talked about a variety of subjects, including cancer journeys, advocacy organization outreach and even personal research projects. My poster discussed the benefits of the Lung Cancer Social Media (#LCSM) community on Twitter. Thank you to my fellow #LCSM Chat Core Members for their valuable suggestions and feedback!
I didn't understand every presentation in the actual AACR meeting -- in at least one presentation I didn't understand ANYTHING (gene editing is very technical) -- but I did come away with a better understanding of the scope of cancer research, some of the issues impeding progress and a list of topics I wanted to explore further. I loved listening to researchers explain cutting-edge work that might lead to better cancer treatments.
Some of the fascinating sessions I attended discussed:
Of course it was impossible to see everything. Some of the fascinating posters and sessions that I missed touched on using viruses to prime immune responses, improving effectiveness of therapies through combination such as immunotherapy and radiation, inhibiting DNA repair in cancer cells and using big data to inform cancer trials.
Aspects of the SSP experience that stood out for me:
I highly recommend any cancer patient advocate who is interested in research to apply for the program! Thank you to the Bonnie J. Addario Lung Cancer Foundation for supporting my application to the AACR Scientist-Survivor Program.
You can view my poster "Online Collaboration & Support in the Lung Cancer Social Media (#LCSM) Community" here.
Consider Endocrine Therapy Responses When Planning Chemo in Breast Cancer Subset
December 9th 2023Results from the ADAPTcycle trial found that endocrine therapy plus ovarian suppression can generate high response rates in patients with HR-positive, early breast cancer, regardless of age.
Read More
Fertility Research ‘Long Overdue’ for Patients With Cervical Cancer
November 30th 2023Cervical cancer survivor Kate Weissman talks recent research on follow-up visits for patients after fertility-sparing surgery, and explains why it’s ‘something that the cervical cancer community is owed.’
Listen
Kadcyla Is the ‘First Therapy to Show Improved Survival’ in a Breast Cancer Subset
December 8th 2023Kadcyla outperformed Herceptin regarding overall- and invasive disease-free survival in patients with HER2-positive early breast cancer that still had remaining invasive disease after undergoing neoadjuvant therapy.
Read More